Legal & General Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $2.4M | Sell |
|
|||||
|
2023
Q1 | $2.42M | Buy |
|
|||||
|
2022
Q4 | $914K | Sell |
|
|||||
|
2022
Q3 | $634K | Buy |
|
|||||
|
2022
Q2 | $703K | Buy |
|
|||||
|
2022
Q1 | $730K | Sell |
|
|||||
|
2021
Q4 | $588K | Buy |
|
|||||
|
2021
Q3 | $2.24M | Buy |
|
|||||
|
2021
Q2 | $2.42M | Buy |
|
|||||
|
2021
Q1 | $1.66M | Buy |
|
|||||
|
2020
Q4 | $1.98M | Sell |
|
|||||
|
2020
Q3 | $1.84M | Sell |
|
|||||
|
2020
Q2 | $2.96M | Buy |
|
|||||
|
2020
Q1 | $2.03M | Buy |
|
|||||
|
2019
Q4 | $2.71M | Buy |
|
|||||
|
2019
Q3 | $811K | Buy |
|
|||||
|
2019
Q2 | $376K | Buy |
|
|||||
|
2019
Q1 | $315K | Buy |
|
|||||
|
2018
Q4 | $192K | Buy |
|
|||||
|
2018
Q3 | $250K | Buy |
|
|||||
|
2018
Q2 | $86K | Buy |
|
|||||
|
2018
Q1 | $40K | Sell |
|
|||||
|
2017
Q4 | $86K | Sell |
|
|||||
|
2017
Q3 | $107K | Buy |
|
|||||
|
2017
Q2 | $78K | Buy |
|
|||||
|
2017
Q1 | $22K | Buy |
|
|||||
|
2016
Q4 | $13K | Buy |
|